Inactive Instrument

Emplicure AB (publ)

Equities

EMPLI

SE0015812391

Advanced Medical Equipment & Technology

BioStock: Emplicure continues development work with Empli03

March 03, 2023 at 02:46 am EST

After receiving results from the PKstudy with Empli03, Emplicure is now moving forward with the formulation development of the candidate. The company also recently initiated a collaboration with OnDosis to develop better pain treatments. BioStock talked to CEO Håkan Engqvist.

Read the full article about Emplicure at biostock.se:

https://www.biostock.se/en/2023/03/emplicure-continues-development-work-with-empli03/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

https://news.cision.com/emplicure-ab/r/biostock-emplicure-continues-development-work-with-empli03,c3726376

Latest news about Emplicure AB (publ)

Emplicure AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
Emplicure AB Appoints Sophia Bailey as Marketing Director	Nov. 13	CI
Emplicure Set to Delist in Sweden as Goldcup 33922 Starts Squeeze Out	Nov. 09	MT
Emplicure Investor Consortium to Transfer Stake to Holding Company	23-10-23	MT
Emplicure AB Forms Nomination Committee	23-10-11	CI
Emplicure AB Receives Research Grant of SEK 1.0 Million from Vinnova	23-09-15	CI
Emplicure AB Hired Johan Magné as Sales Director	23-08-29	CI
Emplicure AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
Emplicure AB Approves Board Appointments	23-06-13	CI
Emplicure AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Emplicure AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-23	CI
Emplicure and OnDosis Form Partnership to Develop Better Pain Treatments	23-01-20	CI
Emplicure AB Announces Results from the Exploratory Clinical PK Study of Its Drug Candidate Empli03	22-12-22	CI
Emplicure AB and Quotient Sciences Announce an Integrated Manufacturing and Clinical Testing Partnership for Emplicure's First Clinical Pharmacokinetic Study for EMPLI03	22-11-29	CI
Emplicure Engages Erik Penser Bank as Liquidity Provider	22-11-23	CI
Emplicure AB Forms Nomination Committee	22-10-28	CI
Emplicure AB Reports Dosing in the First Phase I Pharmacokinetic Study for EMPLI03, Intended for the Treatment of Moderate to Severe Pain	22-10-27	CI
Drugmaker Emplicure Appoints Co-Founder as CEO	22-09-19	MT
Emplicure AB Appoints Håkan Engqvist as President	22-09-19	CI
Emplicure AB Appoints Håkan Engqvist as CEO	22-09-19	CI
Uk Authorities Approves Emplicure's Application to Conduct Clinical Pharmacokinetic Study of Empli03	22-09-06	CI
Certain Shares of Emplicure AB are subject to a Lock-Up Agreement Ending on 25-JUN-2022.	22-06-24	CI
Emplicure AB Announces Board Changes	22-04-06	CI
Emplicure AB Signs Development Agreement with Uppsala University Regarding Biological Medicines	22-04-05	CI
Emplicure AB Announces A Patent Is Set to Be Granted in Australia for Inhalation of Pharmaceuticals	22-04-01	CI

Chart Emplicure AB (publ)

Duration

Period

More charts

Company Profile

Emplicure AB is a provider of research and development services. The Company is located in Uppsala, Sweden.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+10.89%	227B
DANAHER CORPORATION	+14.69%	198B
INTUITIVE SURGICAL, INC.	+18.59%	142B
BOSTON SCIENTIFIC CORPORATION	+31.00%	111B
SIEMENS HEALTHINEERS AG	+0.80%	64.16B
EDWARDS LIFESCIENCES CORPORATION	+18.85%	54.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.82%	51.41B
AGILENT TECHNOLOGIES, INC.	+10.01%	45.32B
GE HEALTHCARE TECHNOLOGIES INC.	+5.37%	37.32B

Other Advanced Medical Equipment & Technology